FirsthandHealth
medRxiv PreprintsInternational19 November 2026

Automated Gland MRI Radiomics for Predicting Time to Pathologic Progression during Prostate Cancer Active Surveillance

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Repeated biopsies burden patients during prostate cancer active surveillance (AS). Existing MRI risk stratification tools avoiding biopsy remain limited by the difficulty of automated lesion segmentation. Purpose: To develop a model integrating gland MRI radiomics and clinicopathologic variables for predicting time to pathologic progression during prostate cancer AS. Materials and Methods: This retrospective single-institution study included men with grade group 1 or favorable grade group 2 prostate cancer undergoing AS with fusion-targeted and systematic biopsy (2010-2025). Gland
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.